Basic Information
Basic information for FLG-AS1-218-43aa
Peptide Name FLG-AS1-218-43aa
Genome Position chr1:152338010-152338089,152341087-152341135[+]
Species Human
Peptide Sequence MANTNNDIAPDFVSEGNASKISSLIIRDWVSLCCPSWRTVAPS
Peptide Length 43
Unique No (FLG-AS1-202-43aa,FLG-AS1-209-43aa,FLG-AS1-211-43aa,FLG-AS1-212-43aa-2,FLG-AS1-213-43aa,FLG-AS1-214-43aa,FLG-AS1-216-43aa,FLG-AS1-217-43aa)
Grand Average of Hydropathicity 0.0047
Relative Molecular Mass 5423.9
Experimental Evidences no
lncRNA ID/Name ENSG00000237975;FLG-AS1
Transcript ID/Name ENST00000669830;FLG-AS1-218
Transcript Length 2502
Coding Ability 0.4333
DNA Sequence Corresponding to Peptide ATGGCAAACACTAATAATGATATTGCTCCTGATTTTGTTTCTGAAGGGAATGCCTCTAAGATTTCTTCATTAATTATAAGAGACTGGGTCTCACTCTGTTGCCCAAGCTGGAGAACAGTGGCACCATCA
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :